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Background and Aims: Despite known Indigenous health and socioeconomic
disadvantage in countries with a Very High Human Development Index, data on the
incidence of stroke in these populations are sparse. With oversight from an Indigenous
Advisory Board, we will undertake a systematic review of the incidence of stroke in
Indigenous populations of developed countries or regions, with comparisons between
Indigenous and non-Indigenous populations of the same region, though not between
different Indigenous populations.
Methods: Using PubMed, OVID-EMBASE, and Global Health databases, we
will examine population-based incidence studies of stroke in Indigenous adult
populations of developed countries published 1990-current, without language
restriction. Non-peer-reviewed sources, studies including <10 Indigenous
People, or with insufficient data to determine incidence, will be excluded. Two
reviewers will independently validate the search strategies, screen titles and
abstracts, and record reasons for rejection. Relevant articles will undergo full-text
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screening, with standard data extracted for all studies included. Quality assessment
will include Sudlow and Warlow’s criteria for population-based stroke incidence
studies, the Newcastle-Ottawa Scale for risk of bias, and the CONSIDER checklist for
Indigenous research.
Results: Primary outcomes include crude, age-specific and/or age-standardized
incidence of stroke. Secondary outcomes include overall stroke rates, incidence rate
ratio and case-fatality. Results will be synthesized in figures and tables, describing data
sources, populations, methodology, and findings. Within-population meta-analysis will
be performed if, and where, methodologically sound and comparable studies allow this.
Conclusion: We will undertake the first systematic review assessing disparities in
stroke incidence in Indigenous populations of developed countries. Data outputs will
be disseminated to relevant Indigenous stakeholders to inform public health and
policy research.
Keywords: epidemiology, incidence, population, stroke, health, aboriginal, indigenous
INTRODUCTION
Rationale
This study has been undertaken to investigate the incidence of
a single health condition—stroke—locating the research in the
context of Indigenous health more broadly. The authors intend
to undertake the research in a way that is culturally responsive
and respectful of the included populations, while also promoting
understanding within the scientific and general communities to
broadly support improved primary prevention of stroke.
The Health of Indigenous Peoples
There are an estimated 370 million Indigenous people living
across 90 countries worldwide (1). Indigenous and tribal
populations (hereafter referred to as Indigenous Peoples,
though we respectfully acknowledge that this may not be the
preferred term for all peoples) are the traditional custodians
of many ecologically and economically diverse regions around
the globe (1, 2). There is great variance in historical,
cultural, epistemological, socioeconomic and environmental
factors within and between these populations, thereby, greatly
enriching the cultural and linguistic diversity of the world
today (1, 3).
The historical consequences of colonization of Indigenous
Peoples across the globe have left a legacy of economic and health
disparity, typically disadvantaging Indigenous populations (4–8).
Many Indigenous Peoples have had lands misappropriated, and
their freedom to practice their traditional cultures and lifestyles
curtailed, resulting in a complex network of disadvantage (4–
6, 9, 10).While income disparity and disadvantage are not limited
to Indigenous populations, in most countries in the world racism
has been particularly virulent toward Indigenous Peoples (4),
and in many cases continues (5–7, 11). While institutionally and
scientifically sanctioned racist views are now widely discredited,
the legacy of these views and policies persists in many ways (6).
In 2007, the United Nations Declaration on the Rights
of Indigenous Peoples (12) affirmed the principles of
Indigenous Peoples’ right to self-determination, including
their rights to freely determine their political status and to
pursue socioeconomic, health and cultural development (12).
Despite these recent gains, Indigenous populations typically
(though not uniformly) experience substantial disadvantages in
socioeconomic status and health outcomes relative to the general
population in their countries (4, 13–19). This is especially true of
countries with a Very High Human Development Index (HDI)
where, on average, the general population enjoy a high quality of
life and life expectancy, yet these indicators often do not extend
to their Indigenous, colonized populations (3, 9, 10, 20).
Our review will be focused specifically on Indigenous
populations living in developed countries, where there is access
to advanced technological infrastructure and financial resources
to manage and prevent stroke. In theory, disparities present
between Indigenous and non-Indigenous populations in these
countries are less likely to reflect nationally reduced access to
resources. By identifying regions where there is relatively less
disadvantage, or who have effectively improved health outcomes
over time, we can examine which approaches and interventions
have been most effective in achieving better health outcomes in
reducing the incidence of stroke.
Role of Conventional Health Research in
Perpetuating Inequalities in Indigenous
Health
Conceptualization of Health
Historically, health research involving Indigenous populations
has not always translated into improved health outcomes for
Indigenous Peoples (21–23). Such research may have been
designed and conducted applying Western notions of health to
the Indigenous context, often without regard for the priorities of
the Indigenous population in question (22, 24, 25). Indigenous
Peoples’ concept of health and often encompasses a more holistic
view, incorporating physical, emotional, mental and spiritual
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health, along with a connection to family, community and their
land (3, 9, 10, 19, 26–28).
Data Quality and Ownership
The incremental gains in health and well-being resulting from
a greater evidence base and improved technology have often
been smaller for some Indigenous populations, relative to their
corresponding non-Indigenous population (3, 21, 29, 30). These
limited gains have partly been attributed to a shortage of
solutions-based research designs, such as studies developing
and evaluating the efficacy of culturally responsive health
interventions (20, 21). Studies lacking rigorous design have led
to poor data quality, providing a poor foundation upon which
to build change (20, 21). Furthermore, much research has not
adhered to data sovereignty principles, including Indigenous
Peoples’ control over the collection and use of their own data
(31). Evidence-based actions are urgently required to address the
health disparities (3, 9, 13, 32).
Community Participation in Research Processes
Health research in Indigenous populations has often been
conducted in an exploitative manner, sometimes resulting in
significant harm to these populations (21, 24, 29, 33–36). Health
inequity cannot be fully understood without considering the
social determinants of health including historic and persistent
systemic and institutional racism (4, 8, 9, 26, 37–39). Yet these
inequalities have frequently been attributed to “poorer behavior”
(40) of Indigenous groups. This depiction of Indigenous health
in terms of “absence, lack, or failure” within scientific and public
communication, policy and practices, reflects the typical deficit
discourse (41). Such discourse promotes inaccurate, harmful
perceptions of existing health disparities, perpetuating individual
and systemic racism, and promoting the continued imbalance
in power between Indigenous and non-Indigenous Peoples (40).
Consequently, Indigenous People of Australia (21, 23) and other
Indigenous Peoples (42) have questioned the utility of health
research in promoting meaningful improvements in their health
and well-being.
Health Research to Support Improvement
of Indigenous Health Outcomes
Indigenous health research and interventions should be
shaped around Indigenous Peoples’ own notion of health,
and conducted in a culturally responsive manner through
Indigenous governance, community consultation, engagement
and partnership (9, 26, 43, 44). Through examining national
and international guidelines on Indigenous health research,
Huria et al. developed the consolidated criteria for strengthening
reporting of health research involving Indigenous Peoples
(CONSIDER statement) (22). This statement identifies eight
research domains (governance; relationships; prioritization;
methodologies; participation; capacity; analysis and findings;
and dissemination) critical to designing and conducting
research which supports improvements in Indigenous health
outcomes (22). We utilized these criteria to inform the design of
this protocol.
Indigenous Health and Stroke
Cardiovascular diseases, including stroke, contribute
significantly, and often disproportionally greater, to the
overall burden of disease among many Indigenous populations
(4, 14, 17, 45, 46). Stroke is particularly significant, being
the second most common cause of death and third greatest
cause of disability worldwide, creating substantial burden to
individuals, families, communities, and health systems (47).
The incidence and outcomes of stroke are the consequence
of a complex interplay between numerous individual and
environmental factors (Figure 1). The social determinants of
health, particularly significant for many Indigenous populations,
may predispose to stroke. This appears to be generally
supported by a disproportionate burden of stroke affecting
these populations, often occurring at younger ages than in
non-Indigenous populations (48–57). However, published data
on the epidemiology of stroke in Indigenous populations are few
and, to date, no reviews have been undertaken to systematically
investigate the incidence of stroke in the Indigenous populations
FIGURE 1 | Pyramid of stroke in Indigenous populations.
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TABLE 1 | PICO framework.
Population Indigenous and non-Indigenous adult populations of developed countries
Intervention Not applicable.
Comparators Indigenous vs. non-Indigenous populations of specific regions, stratified by:
1. Sex
2. Age group
3. Urban and rural/remote location
Note, direct comparisons between different Indigenous populations will not be undertaken.
Outcomes Primary: Crude, age-specific or age-standardized incidence (first-ever-in-a-lifetime) rates of stroke and their rate ratios;
Secondary: attack rates (all cases) of stroke; case-fatality
globally. Such information is urgently needed to underpin
advocacy for evidence-based, effective health interventions (20).
The purpose of this study is to undertake a systematic review
of peer-reviewed data to provide a greater understanding of
the incidence of stroke (including ischemic stroke, spontaneous
intracerebral hemorrhage and non-traumatic subarachnoid
hemorrhage, and excluding transient ischemic attacks) among
Indigenous Peoples in developed countries. This information
will be used to identify gaps in knowledge to guide future
research, and to inform healthcare policy development and
service reform to reduce inequities and improve stroke health
outcomes following stroke in Indigenous populations.
OBJECTIVES
To synthesize published data on the incidence of stroke and
its pathological types in Indigenous populations of developed
countries/regions, with comparisons (where available) made
between Indigenous and non-Indigenous populations, and
within Indigenous populations including by sex, age groups
and location (i.e., urban, rural, and remote populations), where
stratified data are provided (Table 1).
Indigenous Governance
This research is being undertaken with oversight from an
Indigenous Advisory Board (co-authors AD, CM, MH, LB, AB,
DW) comprised of Indigenous researchers from different high-
income countries. This is to ensure all aspects of the research,
including the design, conduct, interpretation, reporting and
publication, are undertaken in a culturally appropriate manner,
and for the benefit of Indigenous Peoples. We sought to engage
these Indigenous researchers in order to be guided by their
local knowledge, insight and perspectives. We have developed
our research aims in accordance with the priorities identified by
relevant Indigenous governing bodies. We further developed the
protocol to adhere to, and honor, Indigenous ethical guidelines
and processes. We acknowledge that all data belongs to the
individuals and communities described in the studies included.
Research outputs will help to inform culturally appropriate health
interventions aimed at primary and secondary prevention of
stroke in Indigenous Peoples.
Definitions
Developed Countries
We identified developed countries as those with a score of ≥0.8
on the United Nations Development Program 2018 Human
Development Index (HDI), indicating a “Very High HDI”
(Appendix 1) (58). Thus, when we refer to “developed countries”
throughout themanuscript, we specifically refer to countries with
a Very High HDI. The term “developed countries” is utilized by
the United Nations (59), though we acknowledge that this term
could be considered somewhat outdated.
The HDI scoring system takes into account overall life
expectancy, literacy and gross national income, but does not
reflect social inequalities, poverty, security or empowerment (58).
Some countries with high HDI scores have minority Indigenous
populations, many of whom do not experience the same levels
of socioeconomic advantage experienced by the non-Indigenous
population of the same region (4, 5, 60). We shall also consider all
states of limited recognition with both a high estimated Human
Development Index and one or more identifiable Indigenous
populations (Appendix 1) (61).
Indigenous Populations
We defined Indigenous populations according to the World
Health Organisation (WHO) definition, namely “communities
that live within, or are attached to, geographically distinct
traditional habitats or ancestral territories, and who identify
themselves as being part of a distinct cultural group, descended
from groups present in the area before modern states were
created and current borders defined. They generally maintain
cultural and social identities, and social, economic, cultural
and political institutions, separate from the mainstream or
dominant society or culture” (2). We acknowledge that the
Indigenous status of some of the Indigenous populations
included in this study may not be officially recognized within
their own countries.
No comprehensive list of Indigenous populations of
developed countries exist. Consequently, identification
(Appendix 1) was based on terms outlined in the UN Permanent
Forum on Indigenous Issues (UNPFII) (62) and a range of
additional sources. We acknowledge that our search string,
by necessity, incorporated certain outdated and potentially
discriminatory terms (i.e., Eskimo, Lapp) to avoid omission of
any relevant studies. In our search strategy, we also included
terms related to geographic regions (i.e., Circumpolar) where a
high proportion of Indigenous people reside. In this study, we
will refer to specific nations, tribal groups, or peoples. Where this
is not possible, we use nation- or region-specific terms, or the
generic term, Indigenous Peoples; we respectfully acknowledge
that these may not be the preferred terms for use.
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Stroke
Cases of stroke will be defined using either:
1. The WHO clinical definition of stroke, inclusive of ischemic
stroke, spontaneous intracerebral hemorrhage and non-
traumatic subarachnoid hemorrhage, and excluding transient
ischemic attacks (63); or
2. International Classification of Diseases definition (including
the full range or subsets of ICD-10 codes I60-I69, or their
equivalent ICD-9 codes) (64).
Population-Based study
A study in which the denominator of the study represents
the whole population of a given area and case ascertainment,
ideally included overlapping sources of information about all
hospitalized, non-hospitalized, fatal and non-fatal stroke events.
Incident Stroke Events
For the purposes of this study, an incident event is defined as first-
ever-in-a-lifetime stroke; to be used when determining incidence
rates. The methodology for how this is determined will differ
between studies.
Total Stroke Events
All strokes occurring within the study period including first-ever
and recurrent stroke events; to be used to determine attack rates
(the rate of all stroke events within the given population).
Standard Population
The proportional age distributions within a population used as




• Language of publication: All
• Year of publication: Articles/reports published from 1990-
current.
• Study designs:
◦ Observational studies of the incidence of stroke, with
the following characteristics:
— Population-based
· Numerator: hospitalized and non-hospitalized,
fatal and non-fatal stroke cases (studies using
WHO STEPwise steps 2 and 3 approach for stroke
surveillance are allowed) (67).
· Denominator: the general population in a given
catchment or geographical area rather than a non-
representative population subset (e.g., a clinically
defined patient group).
— Either prospective or retrospective data collection.
• Data sources used in the studies included:
◦ Population-based active case finding of fatal and non-
fatal cases.
◦ Administrative data.
◦ Hospital-based stroke events covering complete
populations (though not necessarily including non-
hospitalized stroke deaths, to allow for broader
study inclusion).
◦ Community-based household stroke surveys.
◦ Disease registry, if near-comprehensive coverage is available
for stroke.
◦ Other sources, deemed appropriate for comprehensive
population coverage.
— Participants:
◦ Indigenous and non-Indigenous populations
of developed countries.
— If a study includes data on an Indigenous population
without a comparator population, we will include this
study in the preliminary data collection in case meta-
analysis of Indigenous stroke incidence rates by region
is deemed appropriate.
◦ Age group: Includes participants aged≥18 years.
◦ Sex: Studies will be included irrespective of whether or not
stratification is provided by sex.
◦ Geographical: Studies will be included when data are
provided at a national, regional, or city/community-specific
level, or by levels of urbanization/remoteness.
• Outcome measures:
◦ Stroke incidence rates: Ideally, we require availability of
crude age-specific (5- or 10-year age bands) incidence rates
or numbers of stroke events and population denominators
sufficient to calculated age-standardized incidence rates of
stroke. However, as this may exclude many studies, we will
maintain flexibility to include studies with wider age bands;
◦ Stroke attack rates: as above;
◦ Rate ratios: Given that methods will vary greatly, we
will compare ratios of incidence and/or attack rates
(Indigenous vs. non-Indigenous), where available
or calculable.
• Stroke types:
◦ We will include studies that provide data on total stroke
only and/or on stroke type. For comparison incidence
of pathological types of stroke, the study subjects should
ideally have neuroimaging verification of the type of stroke
in ≥70% of subjects (68, 69), although we will also accept
administrative data using International Classification of
Diseases (ICD) classification.
• Publication type:
◦ Original peer-reviewed research published as a letter,
abstract, or original scientific report which include sufficient
data to meet the above inclusion criteria.
Exclusion
• Study design:
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◦ Study designs that do not provide sufficient information to
derive incidence rates. These will include:
Case-control studies which do not have population-
based ascertainment, case report/series, qualitative,
review, editorial, intervention, experiment,
program evaluation;
Cohort studies where the participants are not
representative of the population at risk of stroke;
Prevalence studies.
• Study population:
◦ Studies including insufficient data to derive incidence rates
of stroke in Indigenous populations. These will include:
Articles where Indigenous data were only reported
as baseline characteristics, were combined with other
ethnic groups, or where few (<10) Indigenous cases
were reported;
Where there is a clinical/diagnostic subpopulation (i.e.,
stroke incidence in a select group of patients with a pre-
existing condition such as atrial fibrillation) rather than
derived from the general population;
Studies not reporting age-specific stroke events and/or
age/sex-specific structure of the denominator sufficient
to calculate incidence and mortality rates per year.
• Studies published before 1990;
• Studies not peer-reviewed;
• Rates and count data only presented graphically, with
insufficient data to derive incidence rates of stroke in
Indigenous populations (after attempts to obtain the data from
authors);
• Studies of stroke mortality only;
• Studies of self-report only (survey).
Information Sources
1. PubMed
2. EMBASE via OVID
3. Global Health via OVID
Search Strategy
Two authors will independently validate the search strategy,
using the search terms outlined in Appendix 2, based on
concepts in the three domains of: (1) Population: Indigenous
and non-Indigenous adults in developed countries, (2) Outcome:
incidence, and (3) Outcome: stroke. The reviewers will
perform searches of database-specific controlled vocabulary and
synonymous or related text words of the title, abstract and
author-selected keywords in each database as applicable. They




Records retrieved from the searches will be cataloged in
EndNote R©. Duplicates will be removed by automation,
supplemented with manual checking.
Selection Process
Using Covidence R©, titles and abstracts of articles will be screened
for relevance by at least two reviewers using a three-question
screening process, as described below. Disagreements will be
resolved through consensus with a third independent reviewer.
Reasons for rejection will be recorded in Covidence R©. Articles
deemed relevant will undergo full-text screening.
The title/abstract screening process includes three
yes/maybe/no questions based on the study inclusion criteria.
If all questions are answered in any combination of “yes” or
“maybe” for a given article, it will be included in the full-
text review. If any questions are answered ’no’ the article
will be excluded. When the questions cannot be answered
based on the abstract, the article will be included in the
full-text review. The following questions will be used to
assess eligibility:
1. Does the article study an identifiable Indigenous population of
a developed country?
2. Does the article include an identifiable Indigenous population
of a developed country?
3. Does the study have an observational population-based design
as defined by the inclusion criteria?
4. Does the article contain incidence (or attack) rates of stroke
for the Indigenous population OR contain original count
and population data, thereby allowing for calculation of
incidence rates?
During the title and abstract screening stage, we will exclude
papers based on the follow-criteria:
1. Duplicates;
2. Not peer-reviewed;
3. Study clearly unrelated to stroke/cardiovascular events in
human subjects;
4. Study clearly not including population-based data from one of
the specified (HDI ≥ 0.8) countries.
During the full-text review stage, we will further exclude papers
based on the following related criteria:
1. Did not incorporate details of the incidence or attack rates of
stroke (or provide sufficient data to allow the calculation of
incidence or attack rates of stroke);
2. Did not include separate details of a specific
Indigenous population;
3. Did not include, at minimum, age groups between 35 and
64 years;
4. Did not include an identifiable Indigenous population at the
individual or ecological level;
5. Did not include crude, age-specific or adjusted incidence (or
attack) rates of stroke or sufficient data (count and population)
in the numerator and denominator to estimate rates for an
Indigenous population;
6. Provided rates in graphical form only;
7. Did not comprise original research to determine incidence
rates (i.e., review articles); and
8. Provided details of incidence (or attack) rates from the same
dataset, and with a period of overlap, as another paper that had
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more comprehensive data (i.e., the article included a shorter
period of observation).
Data Collection Process
Article details will be extracted independently by reviewers
from selected papers into a predesigned template in Microsoft
Excel (Appendix 3). Variables will include author, year of
publication, region, Indigenous population, study design and
sample characteristics. Studies will be grouped according to
the type(s) of epidemiological data on stroke presented. We
anticipate that the content of this data extraction list will be final,
but we will pilot this and make changes as necessary.
Data Items
Article details will be extracted independently by reviewers
from selected papers into a predesigned template in Microsoft
Excel. Studies will be grouped according to the type(s) of
epidemiological data on stroke presented. We anticipate that the
content of this data extraction list will be final, but we will pilot it
and make changes as necessary.
Outcomes and Prioritization
Primary
Crude, age-specific or age-standardized incidence (first-ever-
in-a-lifetime) of stroke in Indigenous and non-Indigenous
populations – standardized to WHO population (65, 66).
Secondary
Crude, age-specific or age-standardized attack rates (all cases) of
stroke; attack rate ratio; case-fatality.
Age Standardization
Where age-specific rates are provided, the age structure of
the WHO Standard Population will be used to calculate
age-standardized stroke incidence (and attack) rates (63).
Additionally, age-standardized rates published in the
papers using other standard populations will be recorded
(if available) recognizing these rates may not be comparable
between populations.
Comparisons
We will examine differences by age, sex and Indigenous status.
We will not directly compare the incidence of stroke between
different Indigenous populations becausemethods differ between
countries with regard to the recognized definition of Indigenous
status, how these data are collected and ascertainment in
Indigenous data (13). Furthermore, through consultation with
Indigenous researchers and stakeholders, we were advised that
certain Indigenous groups do not wish to be compared to other
Indigenous populations. Therefore, we will not make any attempt
to draw comparisons between different Indigenous groups.
Risk of Bias in Individual Studies
Risk of bias analysis will be conducted for all research papers.
Original research published as an abstract or research letter only
will be identified with an asterisk (∗) in the tables.
The validity of study hypotheses on epidemiological indices
of Indigenous stroke will be assessed in applicable cases using
TABLE 2 | Risk of bias assessment in individual studies, using the
Newcastle-Ottawa Scale*.





*Newcastle-Ottawa Scale (70) for non-randomized studies, the maximum score for all
fields is 9 (selection 4, comparability 2, outcomes/exposure 3).
the Newcastle-Ottawa Scale (NOS) and reported according to the
layout of Table 2 (70). This scale was selected due to its utility in
assessing the quality of observational studies.
In addition to the NOS, we will assess whether each study
of stroke incidence was conducted according to “ideal” study
criteria, described by Sudlow andWarlow (71) in 1996 (Table 3).
Although these were later updated by Feigin and Vander Hoorn
in 2004 (72) and then again by Feigin et al. in 2018 (68), we
will use the original Sudlow and Warlow criteria (71), given the
later updates may have been published after the selected studies
had commenced.
Quality of Reporting in Individual Studies
Studies will be assessed using the consolidated criteria for
strengthening reporting of health research involving Indigenous
Peoples (CONSIDER) checklist, a collaborative synthesis and
prioritization of existing national and international statements
and guidelines (Table 4) (22). We will examine whether
individual studies specifically addressed these eight domains. As
we recognize the limitations of determining this solely based on
published material, if at least one of the items within a given
domain is addressed, we will consider that the study has met
criteria for that domain. We will report a proportion of studies
that address these individual domains, using a radar plot. Total
number of studies permitting, we will generate similar plots for
different time epochs and different regions.
Data Synthesis
We will conduct a narrative review of studies that provide
estimates of incidence (and attack) rates and rate ratios. Results
will be synthesized in figures and tables. These will include
descriptions of data sources, populations, methodology, and
findings. We anticipate heterogeneity in the data from included
studies (population data sources used, study period, age and sex
stratification, population size, and comparators). Therefore, we
are not planning to conduct a meta-analysis across countries.
We will attempt this within countries, subject to (1) a sufficient
number of studies and (2) comparable design of studies.
1. Age standardized rate
a. Use data provided
b. Recalculate according to WHO population
2. Age standardized rate ratio
a. Use data provided
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TABLE 3 | Criteria for Basic and Advanced Population-Based Stroke and TIA Incidence Studies.
Study 1 Study 2 Study 3 Study 4 Study 5 Study 6
Standard definitions
World Health Organization clinical definition Yes Yes Yes
First-ever-in-a-lifetime stroke Yes
Standard methods
Complete population-based case ascertainment, based on multiple overlapping sources Yes Yes Yes
Prospective study design, ideally with “hot pursuit” of cases Yes Yes Yes Yes
Large, well-defined, stable population Yes
Reliable method for estimating denominator Yes
Standard data-presentation
Whole years of data Yes Yes
Not >5 years of data averaged together Yes
Men and women presented separately Yes Yes
Include ages up to ≥85 years if possible Yes
Standard mid-decade age bands (e.g., 55 to 64 years) used in publications Yes
Unpublished 5-year age bands available for comparison with other studies Yes
Presentation of 95% confidence intervals around incidence rates Yes
“Ideal” study (i.e., meets all criteria) No No No No No Yes
Adapted from Sudlow and Warlow (71).
b. WHO standard rate ratio (if age-specific numbers and
denominator available)
3. Trends over time (if available)
4. A map showing where these studies arise and where data
are unavailable.
Meta-Analysis and Meta-Bias(ES)
Due to anticipated heterogeneity of data, and as we are not
making comparisons between different Indigenous populations,
we expect little or no potential for meta-analysis or assessment of
meta-biases across studies. However, we will aim to determine
whether there is any role for meta-analysis in this setting.
Specifically, if there are a sufficient number of “gold-standard”
incidence studies with comparable methodology for the same
Indigenous population to allow for comparison, meta-analysis
(stratified by jurisdiction) may be undertaken.
Confidence in Cumulative Evidence
Due to anticipated heterogeneity of data, and as we are not
making comparisons between different Indigenous populations,
we will not be reporting confidence in cumulative evidence.
DISCUSSION
In this study, we will undertake the first systematic review
assessing disparities in stroke incidence in Indigenous
populations of developed countries worldwide. Our findings will
be placed in the broader context of health research involving
Indigenous Peoples, recognizing (though not aiming to measure)
the social determinants of health. We anticipate that the
incidence of stroke will generally, though not uniformly, be
greater in Indigenous populations than their respective non-
Indigenous populations. Our systematic methodology will
offer critical insights into gaps in the availability and quality of
data on stroke incidence in Indigenous populations, as well as
methodological challenges and suitable approaches to obtaining
valid estimates. High-quality data are imperative for informing
effective health interventions, and appropriate consultation and
insight from Indigenous stakeholders critical to their efficacy.
Indigenous health research is often framed placing those of
white majorities (for example, non-Hispanic ethnicity in the
USA) as the referent category, with the implication of this being
the “normal” group. This largely arises because the referent group
is ideally a larger group than the comparison group, thereby
providing estimates that are more robust. An alternative view is
that Indigenous or minority groups could be referent, and other
populations could be the comparison group. Use of this strategy
has to be considered in the context of the population size.
Strengths and Limitations
Amajor strength of the planned review is the input and oversight
from the outset of Indigenous researchers from around the world
into the conceptualization and study design. These Indigenous
researchers represent a range of Indigenous cultures, thereby
providing a broad perspective of Indigenous cultures. This new
international partnership will strengthen collaboration, with
potential to develop innovative ways of working in the global
Indigenous stroke space. Not only will we provide information on
the incidence rates of stroke in various Indigenous populations of
developed countries worldwide, but we will also appraise whether
the studies in which these data are published appear to have been
undertaken with the appropriate cultural lens. Consequently,
the review will not only provide insight into disparities that
need to be addressed but will also contribute to establishing
frameworks that optimize the benefit of future research for
Indigenous Peoples.
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TABLE 4 | Consider checklist: items to include when reporting health research involving Indigenous Peoples.
Governance
1. Describe partnership agreements between the research institution and Indigenous-governing organization for the
research.
2. Describe accountability and review mechanisms within the partnership agreement that addresses harm
minimization.
3. Specify how the research partnership agreement includes protection of Indigenous intellectual property and
knowledge arising from the research.
Prioritization
4. Explain how the research aims emerged from priorities identified by either Indigenous stakeholders, governing
bodies, funders, non-government organizations, stakeholders, consumers, and empirical evidence.
Relationships (Indigenous stakeholders/participants and Research team)
5. Specify measures that adhere and honor Indigenous ethical guidelines, processes, and approvals for all relevant
Indigenous stakeholders.
6. Report how Indigenous stakeholders were involved in the research processes.
7. Describe the expertise of the research team in Indigenous health and research.
Methodologies
8. Describe the methodological approach of the research including a rationale of methods used and implication for
Indigenous stakeholders.
9. Describe how the research methodology incorporated consideration of the physical, social, economic and cultural
environment of the participants and prospective participants.
Participation
10. Specify how individual and collective consent was sought to conduct future analysis on collected samples and
data.
11. Described how the resource demands (current and future) placed on Indigenous participants and communities
involved in the research were identified and agreed upon.
12. Specify how biological tissue and other samples including data were stored, explaining the processes of removal
from traditional lands, if done, and of disposal (Not applicable for this current study).
Capacity
13. Explain how the research supported the development and maintenance of Indigenous research capacity.
14. Discuss how the research team undertook professional development opportunities to develop the capacity to
partner with Indigenous stakeholders.
Analysis and interpretation
15. Specify how the research analysis and reporting supported critical inquiry and a strength-based approach
inclusive of Indigenous values.
Dissemination
16. Describe the dissemination of the research findings to relevant Indigenous governing bodies and peoples.
17. Discuss the process for knowledge translation and implementation to support Indigenous advancement.
Adapted from Huria et al. (22) with permissions.
There are also several limitations in this study. In our
protocol, we have endeavored to incorporate search terms that
identify as many as possible of the various Indigenous Peoples
of developed countries; however, we acknowledge that our list
cannot realistically be exhaustive. We have based our definition
of developed countries on the HDI, including only those
countries fulfilling criteria for “very high human development,” in
which excellent health indices and life-expectancy of the general
population typically do not extend to Indigenous minority
groups. However, we acknowledge that the chosen cut-point
for HDI dichotomization is ultimately arbitrary, and that the
term “developed countries” could be considered somewhat
outdated and colonialistic, despite being the current preferred
term used by the United Nations. Additionally, we anticipate
substantial heterogeneity in the number of studies per region,
data quality, and methodologies (including case ascertainment
and identification of Indigenous status) of included studies. We
are also not examining the “gray literature”; therefore, the data
retrieved will be less comprehensive than if we included this
literature. However, it is likely that exclusion of the gray literature
will result in greater overall accuracy, given the rigorous methods
inherent in peer review processes. Assessment criteria for stroke
incidence studies (71) may not be appropriate for those studies
conducted prior to the publication of these recommendations, so
will be acknowledged when this occurs. Quality assessment using
the NOS may be limited by bias due to inter-observer variation
(73). Ascertaining the extent of Indigenous engagement based
on information provided explicitly within the published studies
will be limited by numerous factors, such as word count limits,
authorship criteria and other similar publication constraints (74).
Additionally, many of these studies will have been published
prior to the development of the CONSIDER statement (or similar
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guidelines), so we may observe a change in reporting over time.
Indeed, deficits in this area may highlight a necessity for changes
in editorial policies to help promote greater methodological
transparency. Finally, while development of this protocol has
benefitted from substantial input and oversight provided by
researchers across many countries, the study was originally
conceptualized by Australian researchers, who are most familiar
with Indigenous health issues and research challenges in the
Australian context. Thus, we acknowledge that aspects of our
commentary are inevitably grounded in this perspective and
may not necessarily be applicable to other Indigenous contexts
worldwide. As the study progresses, we anticipate that our
perspective will be broadened, particularly given the broader
oversight from the Indigenous Advisory Board.
Dissemination Plan
We will submit the completed review for publication in a peer-
reviewed journal. Prior to submission, the manuscript will be
scrutinized by the Indigenous Advisory Board, who will assess
and advise whether all aspects of the study have been conducted
with the priorities of the Indigenous Peoples remaining central
throughout the process. Both this protocol and the completed
review manuscript will also be included in the doctoral thesis
of one of the authors (AHB). We will present the findings at
professional fora and Indigenous health conferences. Further, we
will communicate results in the form of oral presentations to
relevant stakeholder and consumer groups, including Indigenous
communities and non-government organizations (i.e., National
Stroke Foundations.). We will also prepare accessible summary
reports using visual graphics and interactive maps and will use
these in our presentations and printedmaterials. This process will
be undertaken with guidance and oversight from our Indigenous
Advisory Board, and additional knowledge sharing mechanisms
will be discussed during the progress of the systematic review.
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et al. Waimānalo Pono Research Hui: a community–academic partnership
to promote native Hawaiian wellness through culturally grounded and
community-driven research and programming. Am J Community Psychol.
(2019) 64:107–17. doi: 10.1002/ajcp.12355
29. Johnstone MJ. Improving the ethics and cultural suitability of Aboriginal
health research. Aboriginal Islander Health Worker J. (1991) 15:10–3.
30. Stephens C, Nettleton C, Porter J, Willis R, Clark S. Indigenous peoples’
health–why are they behind everyone, everywhere? Lancet. (2005) 366:10–
3. doi: 10.1016/S0140-6736(05)66801-8
31. Research Data Alliance International Indigenous Data Sovereignty Interest
Group. “CARE Principles for Indigenous Data Governance.” The Global
Indigenous Data Alliance. (2019). Available online at: www.GIDA-global.org
(accessed December 22, 2020).
32. Angell BJ, Muhunthan J, Irving M, Eades S, Jan S. Global systematic review of
the cost-effectiveness of indigenous health interventions. PLoS ONE. (2014)
9:e111249–e. doi: 10.1371/journal.pone.0111249
33. Kilkenny MF, Harris DM, Ritchie EA, Price C, Cadilhac DA, National Stroke
F. Hospital management and outcomes of stroke in Indigenous Australians:
evidence from the 2009 Acute Care National Stroke Audit. Int J Stroke. (2013)
8:164–71. doi: 10.1111/j.1747-4949.2011.00717.x
34. Napier AD, Ancarno C, Butler B, Calabrese J, Chater A,
Chatterjee H, et al. Culture and health. Lancet. (2014) 384:1607–
39. doi: 10.1016/S0140-6736(14)61603-2
35. Mello MM, Wolf LE. The Havasupai Indian tribe case — lessons for
research involving stored biologic samples. N Engl J Med. (2010) 363:204–
7. doi: 10.1056/NEJMp1005203
36. Ortiz-Prado E, Simbana-Rivera K, Gomez-Barreno L, Tamariz L, Lister A,
Baca JC, et al. Potential research ethics violations against an indigenous
tribe in Ecuador: a mixed methods approach. BMC Med Ethics. (2020)
21:100. doi: 10.1186/s12910-020-00542-x
37. Jones CP. Invited commentary: “race,” racism, and the practice
of epidemiology. Am J Epidemiol. (2001) 154:299–304. Discussion
5-6. doi: 10.1093/aje/154.4.299
38. Larson A, Gillies M, Howard PJ, Coffin J. It’s enough to make you sick: the
impact of racism on the health of Aboriginal Australians. Aust N Z J Public
Health. (2007) 31:322–9. doi: 10.1111/j.1753-6405.2007.00079.x
39. Henry BR, Houston S, Mooney GH. Institutional racism in
Australian healthcare: a plea for decency. Med J Aust. (2004)
180:517–20. doi: 10.5694/j.1326-5377.2004.tb06056.x
40. Bond CJ, Singh D. More than a refresh required for closing the
gap of Indigenous health inequality. Med J Aust. (2020) 212:198–
9.e1. doi: 10.5694/mja2.50498
41. Fogarty W, Lovell M, Langenberg J, Heron MJ. Deficit Discourse and
Strengths-based Approaches: Changing the Narrative of Aboriginal and Torres
Strait Islander Health andWellbeing. Melbourne: The Lowitja Institute (2018).
42. Sinclair KiA, Muller C, Noonan C, Booth-LaForce C, Buchwald
DS. Increasing health equity through biospecimen research:
identification of factors that influence willingness of Native
Americans to donate biospecimens. Prevent Med Rep. (2021)
21:101311. doi: 10.1016/j.pmedr.2021.101311
43. Egeland GM,Harrison GG. Health disparities: promoting Indigenous Peoples’
health through traditional food systems and self-determination. In: Spigelski
D, Kuhnlein HV, Erasmus B, Burlingame B, editors. Indigenous Peoples’ Food
Systems and Well-Being: Interventions and Policies for Healthy Communities.
Rome: Food and Agriculture Organization of the United Nations (2013). p.
9–22.
44. Fitzpatrick EFM, Martiniuk ALC, D’Antoine H, Oscar J, Carter M, Elliott
EJ. Seeking consent for research with indigenous communities: a systematic
review. BMCMed Ethics. (2016) 17:65. doi: 10.1186/s12910-016-0139-8
45. Lucero AA, Lambrick DM, Faulkner JA, Fryer S, Tarrant MA, Poudevigne
M, et al. Modifiable cardiovascular disease risk factors among indigenous
populations.Adv Prevent Med. (2014) 2014:547018. doi: 10.1155/2014/547018
46. Snodgrass J. Health of indigenous circumpolar populations. Ann Rev
Anthropol. (2013) 42:69–87. doi: 10.1146/annurev-anthro-092412-155517
47. Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. (2017)
120:439–48. doi: 10.1161/CIRCRESAHA.116.308413
48. Balabanski AH, Newbury J, Leyden JM, Arima H, Anderson CS, Castle S, et
al. Excess stroke incidence in young Aboriginal people in South Australia:
Pooled results from two population-based studies. Int J Stroke. (2018) 13:811–
4. doi: 10.1177/1747493018778113
49. Boden-Albala B, Allen J, Roberts ET, Bulkow L, Trimble B. Ascertainment
of Alaska native stroke incidence, 2005-2009: lessons for assessing the
global burden of stroke. J Stroke Cerebrovasc Dis. (2017) 26:2019–
26. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.007
50. Feigin VL, Krishnamurthi RV, Barker-Collo S, McPherson KM, Barber PA,
Parag V, et al. 30-year trends in stroke rates and outcome in Auckland, New
Frontiers in Neurology | www.frontiersin.org 11 April 2021 | Volume 12 | Article 661570
Balabanski et al. Stroke Incidence in Indigenous Populations
Zealand (1981-2012): a multi-ethnic population-based series of studies. PLoS
ONE. (2015) 10:e0134609. doi: 10.1371/journal.pone.0134609
51. Zhang Y, Galloway JM, Welty TK, Wiebers DO, Whisnant JP,
Devereux RB, et al. Incidence and risk factors for stroke in
American Indians: the Strong Heart Study. Circulation. (2008)
118:1577–84. doi: 10.1161/CIRCULATIONAHA.108.772285
52. Martens PJ, Bartlett JG, Prior HJ, Sanguins J, Burchill CA, Burland EMJ, et
al. What is the comparative health status and associated risk factors for the
Métis? A population-based study in Manitoba, Canada. BMC Public Health.
(2011) 11:814. doi: 10.1186/1471-2458-11-814
53. Siri SRA, Eliassen BM, Broderstad AR,MelhusM,MichalsenVL, Jacobsen BK,
et al. Coronary heart disease and stroke in the Sami and non-Sami populations
in rural Northern andMid Norway-the SAMINOR Study.Open Heart. (2020)
7:e001213. doi: 10.1136/openhrt-2019-001213
54. Muller CJ, Alonso A, Forster J, Vock DM, Zhang Y, Gottesman RF, et al. Stroke
incidence and survival in American Indians, blacks, and whites: the strong
heart study and atherosclerosis risk in communities study. J Am Heart Assoc.
(2019) 8:e010229. doi: 10.1161/JAHA.118.010229
55. Dos Santos A, Mohr K, Jude M, Simon NG, Parsons M, Eades S, et al. A
prospective analysis of stroke recognition, stroke risk factors, thrombolysis
rates and outcomes in Indigenous Australians from a large rural referral
hospital. Intern Med J. (2020). doi: 10.1111/imj.15080. [Epub ahead of print].
56. Nakagawa K, Koenig MA, Asai SM, Chang CW, Seto TB. Disparities among
Asians and native Hawaiians and Pacific Islanders with ischemic stroke.
Neurology. (2013) 80:839–43. doi: 10.1212/WNL.0b013e3182840797
57. Nakagawa K, Koenig MA, Seto TB, Asai SM, Chang CW. Racial disparities
among Native Hawaiians and Pacific Islanders with intracerebral hemorrhage.
Neurology. (2012) 79:675–80. doi: 10.1212/WNL.0b013e3182608c6f
58. United Nations Development Programme.Human Development Index (HDI).
Available online at: http://hdr.undp.org/en/content/human-development-
index-hdi (accessed June 20, 2020).
59. United Nations. Human Development Report 2019. United Nations
Development Programme, New York, NY. (2019). Available online at:
http://hdr.undp.org/sites/default/files/hdr2019.pdf (accessed February 24,
2021).
60. Cooke M, Mitrou F, Lawrence D, Guimond E, Beavon D. Indigenous
well-being in four countries: an application of the UNDP’S human
development index to indigenous peoples in Australia, Canada, New
Zealand, and the United States. BMC Int Health Hum Rights. (2007)
7:9. doi: 10.1186/1472-698X-7-9
61. National Statistics of the Directorate-General of Budget, Accounting and
Statistics. Republic of China (Taiwan), National Statistics. Taipei City,
Taiwan. Available online at: https://eng.stat.gov.tw/ct.asp?xItem=25280&
ctNode=6032&mp=5 (accessed January 25, 2021).
62. United Nations. Indigenous Peoples Fact Sheet. (2017). Available online
at: https://www.un.org/esa/socdev/unpfii/documents/5session_factsheet1.pdf
(accessed June 9, 2020).
63. Hatano S. Experience from a multicentre stroke register: a preliminary report.
Bull World Health Organ. (1976) 54:541–53.
64. Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using
international classification of diseases, revisions 9 and 10. Stroke. (2005)
36:1776–81. doi: 10.1161/01.STR.0000174293.17959.a1
65. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M. Age
Standardization of Rates: A NewWHO Standard. GPE Discussion Paper Series:
No. 31. Geneva: World Health Organization (2001).
66. National Institute of Health. World (WHO 2000-2025) Standard. USA:
National Cancer Institute (2020). Available online at: https://seer.cancer.gov/
stdpopulations/world.who.html (accessed January 29, 2021).
67. World Health Organization. Noncommunicable D, Mental Health C.
WHO STEPS Stroke Manual : The WHO STEPwise Approach to Stroke
Surveillance/Noncommunicable Diseases and Mental Health, World Health
Organization. Geneva: World Health Organization (2005).
68. Feigin V, Norrving B, Sudlow CLM, Sacco RL. Updated criteria for
population-based stroke and transient ischemic attack incidence studies for
the 21st century. Stroke. (2018) 49:2248–55. doi: 10.1161/STROKEAHA.118.
022161
69. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology:
a review of population-based studies of incidence, prevalence, and
case-fatality in the late 20th century. Lancet Neurol. (2003) 2:43–
53. doi: 10.1016/S1474-4422(03)00266-7
70. GA Wells BS, D O’Connell, J Peterson, V Welch, M Losos, P Tugwell. The
Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised
Studies in Meta-analyses. Avaialble online at: http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp (accessed July 18, 2020).
71. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes
studies comparable? Stroke. (1996) 27:550–8. doi: 10.1161/01.STR.27.3.550
72. Feigin V, Hoorn SV. How to study stroke incidence.
Lancet. (2004) 363:1920. doi: 10.1016/S0140-6736(04)1
6436-2
73. Hartling L,Milne A, HammMP, Vandermeer B, AnsariM, Tsertsvadze A, et al.
Testing the Newcastle Ottawa Scale showed low reliability between individual
reviewers. J Clin Epidemiol. (2013) 66:982–93. doi: 10.1016/j.jclinepi.2013.
03.003
74. Jones J, Cunsolo A, Harper SL. Who is research serving? A systematic
realist review of circumpolar environment-related Indigenous health
literature. PLoS ONE. (2018) 13:e0196090. doi: 10.1371/journal.pone.01
96090
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
The Handling Editor declared a past co-authorship with two of the authors,
AD and MP.
Copyright © 2021 Balabanski, Dos Santos, Woods, Thrift, Kleinig, Suchy-Dicey,
Siri, Boden-Albala, Krishnamurthi, Feigin, Buchwald, Ranta, Mienna, Zavaleta,
Churilov, Burchill, Zion, Longstreth, Tirschwell, Anand, Parsons, Brown, Warne,
Harwood and Katzenellenbogen. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) and
the copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Neurology | www.frontiersin.org 12 April 2021 | Volume 12 | Article 661570
